The roles of RGS proteins in cardiometabolic disease
British Journal of Pharmacology · 2024
DOI: 10.1111/bph.16076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Samantha M McNeill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: RGS Proteins, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Research Council.
Abstract (Originalsprache)
G protein‐coupled receptors (GPCRs) are the most prominent receptors on the surface of the cell and play a central role in the regulation of cardiac and metabolic functions. GPCRs transmit extracellular stimuli to the interior of the cells by activating one or more heterotrimeric G proteins. The duration and intensity of G protein‐mediated signalling are tightly controlled by a large array of intracellular mediators, including the regulator of G protein signalling (RGS) proteins. RGS proteins selectively promote the GTPase activity of a subset of Gα subunits, thus serving as negative regulators in a pathway‐dependent manner. In the current review, we summarise the involvement of RGS proteins in cardiometabolic function with a focus on their tissue distribution, mechanisms of action and dysregulation under various disease conditions. We also discuss the potential therapeutic applications for targeting RGS proteins in treating cardiometabolic conditions and current progress in developing RGS modulators. LINKED ARTICLES This article is part of a themed issue Therapeutic Targeting of G Protein‐Coupled Receptors: hot topics from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2021 Virtual Annual Scientific Meeting. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.14/issuetoc
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
- ARC Centre for Cryo-Electron Microscopy of Membrane Proteins (CCeMMP), Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Förderung
- Australian Research Council
Zitieren
APA
McNeill, S. M., & Zhao, P. (2024). The roles of RGS proteins in cardiometabolic disease. British Journal of Pharmacology. https://doi.org/10.1111/bph.16076
Vancouver
McNeill SM, Zhao P. The roles of RGS proteins in cardiometabolic disease. British Journal of Pharmacology. 2024. doi:10.1111/bph.16076
BibTeX
@article{McNeill2024,
author = {McNeill, Samantha M and Zhao, Peishen},
title = {The roles of RGS proteins in cardiometabolic disease},
journal = {British Journal of Pharmacology},
year = {2024},
doi = {10.1111/bph.16076}
}
EUVIMED